Vericel Corp Ord (VCEL)

Exchange
NASDAQ
Symbol
VCEL
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    54.40
  • High
    57.22
  • Low
    54.32
  • Close
    56.50
  • Volume
    720,634

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
4.73
Receivables turnover
3.74
Payables turnover
2.77
Working capital turnover
1.24
Days of inventory on hand (DOH)
77.12
Days of sales outstanding (DSO)
97.49
Number of days of payables
131.69
Fixed asset turnover
4.74
Total asset turnover
0.56
 Liquidity ratios
Current ratio
4.49
Quick ratio
3.55
Cash ratio
2.39
Cash conversion cycle
42.92
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.57
Interest coverage
-6.14
 Profitability ratios
Gross profit margin
68.64%
Operating profit margin
-3.27%
Pretax margin
-1.20%
Net profit margin
-1.61%
Operating return on assets (Operating ROA)
-1.83%
Return on assets (ROA)
-0.90%
Return on total capital
-1.63%
Return on equity (ROE)
-1.41%